Rise In Hepatitis Cases Prevalence Fueling the Growth Of The Market Due To Increasing Global Disease Burden And Demand For Early Diagnosis: Transformative Forces Shaping the Hepatitis C Testing Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hepatitis C Testing Industry Market Size Be by 2025?
The market size for hepatitis C testing has seen robust growth over the past few years. The market, which was valued at $1.24 billion in 2024, is predicted to grow to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. Factors such as increase in the prevalence of hepatitis C, enlargement of public health initiatives, a surge in the use of intravenous drugs, heightened awareness of the risks associated with hepatitis C, and governmental monetary support for controlling infectious diseases have contributed to the growth during the historical period.

What's the Long-Term Growth Forecast for the Hepatitis C Testing Market Size Through 2029?
The market size for hepatitis C testing is projected to experience significant growth in the upcoming years. It's anticipated to escalate to $1.68 billion in 2029 with a compound annual growth rate (CAGR) of 6.2%. The growth during the forecast period can be linked to the surging need for early detection of the disease, expanded healthcare accessibility, enhanced focus on preventive healthcare, backing by international health bodies, and governmental plans to eliminate hepatitis C. The forecast period is most likely to witness trends such as the uptake of multiplex diagnostic platforms, incorporation of artificial intelligence (AI) into diagnostic tools, a movement toward home-based testing kits, bolstered collaboration for test creation, and the introduction of affordable testing solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

What Are the Key Growth Drivers Fueling the Hepatitis C Testing Market Expansion?
The increase in hepatitis cases is projected to drive the growth of the hepatitis C testing market. Hepatitis C, a viral infection leading to liver inflammation, can cause severe liver damage if not treated on time. The growing number of hepatitis cases is mainly due to low vaccination rates that leave many people unprotected, encouraging the virus to spread. Hepatitis C testing is essential for early detection of the virus, enabling immediate treatment to prevent severe liver damage and complications. It also helps identify infected persons to curb the propagation and improve disease control. For example, in April 2024, the World Health Organization (WHO), a Switzerland-based global public health agency, reported that over 50 million people worldwide live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the increasing prevalence of hepatitis cases is contributing to the growth of the hepatitis C testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

What Are the Key Trends Driving Hepatitis C Testing Market Growth?
Top corporations in the hepatitis C testing market are striving to create innovative solutions, such as dual antigen-antibody diagnostic tests, to enhance the efficiency of infection screening and monitoring. This kind of diagnostic test identifies viral proteins or antigens as well as immune response proteins or antibodies, hence it can detect both current and previous infections, providing a complete assessment of the infection's status. In July 2023, for example, Roche Diagnostics India Pvt. Ltd., an Indian diagnostic test and systems provider, introduced their Elecsys HCV Duo, a fully automated immunoassay with the capacity to independently and concurrently detect HCV antigens and antibodies from a single plasma or serum sample. This breakthrough supports early detection, aids in patient care, and aligns with India's overarching plan to eradicate hepatitis C through extensive and prompt screening.

How Is the Hepatitis C Testing Market Segmented?
The hepatitis c testing market covered in this report is segmented -

1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests
2) By Product: Test Kits, Instruments, Reagents, Consumables
3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing
4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis
5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:
1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)
2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)
3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

Which Companies Are Leading the Charge in Hepatitis C Testing Market Innovation?
Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.

Which Regions Are Leading the Global Hepatitis C Testing Market in Revenue?
North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24559

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.